Tags:HealthTechMarketProductPublicSpecialty
Emergent BioSolutions provides specialty products for civilian and military populations that address intentional and naturally emerging public health threats.
Member count: 201-500
Total raised: $189M
Founded date: 2006

Investors 1

Funding Rounds 3

DateSeriesAmountInvestorsDeal News
09.12.2015-$105M-finsmes.co...
28.07.2014-$62M-finsmes.co...
04.12.2013Series B$22M-finsmes.co...

Mentions in press and media 9

DateTitleDescriptionCategoryAuthorSource
10.08.2018Emergent B...Emergent BioSolutions Inc. (NY...USA-finsmes.co...
10.08.2018Term Sheet...MORE DEBT Happy Friday, Term ...--fortune.co...
08.12.2015PaxVax Rec...PaxVax, Inc., a Redwood City, ...USA-finsmes.co...
30.07.2014PaxVax Sec... REDWOOD CITY, CA, Specialty ...--vcnewsdail...
29.07.2014 PaxVax...PaxVax, a biopharmaceuticals c...--socaltech....
28.07.2014PaxVax Clo...PaxVax, Inc., a Redwood City, ...USA-finsmes.co...
04.12.2013PaxVax Com...PaxVax Inc., a San Diego, Cali...funding S...-finsmes.co...
04.12.2013PaxVax sna...PaxVax CEO Ken Kelley Menlo P...Clinical D...-fiercebiot...
09.11.2009 PaxVax...San Diego-based PaxVax, a firm...--socaltech....